XML 57 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 126,236 $ 159,052 $ 164,822
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 92,384 62,988 42,770
Non-cash lease expense 9,549 16,254 9,652
Amortization of marketing contract intangible 7,211 7,211 7,211
Amortization of deferred revenue (1,755) (1,775) (1,953)
Amortization of deferred financing costs and debt discount 6,327 3,872 3,016
Impairment of goodwill 14,848 0 0
Income from equity method investments (31,433) (31,683) (24,575)
Dividends from equity method investments 28,729 22,954 20,831
Other non-cash adjustments 2,697 2,718 1,959
Changes in assets and liabilities:      
Accounts receivable 21,570 (9,071) 292
Inventories and other current assets (131) 2,233 55
Accounts payable and other current liabilities (20,729) 18,564 (1,913)
Accounts receivable/payable to related parties (34,498) (58,368) 67,161
Non-current assets and liabilities, net 4,314 (2,781) (14,166)
Net cash provided by operating activities 225,319 192,168 275,162
Cash flows from investing activities:      
Purchases of property, plant and equipment (96,101) (141,098) (23,052)
Proceeds from sales of property, plant and equipment 1,717 143 275
Purchases of intangible assets (4,247) (5,597) (964)
Business Combination, net of cash acquired 0 (625,622) 0
Distributions from equity method investments 9,002 1,737 8,774
Equity method investment contributions 0 0 (1,393)
Net cash used in investing activities (89,629) (770,437) (16,360)
Cash flows from financing activities:      
Proceeds from issuance of common units, net of underwriters' discount 0 3,096 0
Distributions to common unitholders - public (38,491) (35,868) (32,462)
Distributions to common unitholders - Delek Holdings (141,534) (135,219) (129,255)
Proceeds from term facility 0 298,511 0
Proceeds from revolving facility 431,800 1,752,300 341,000
Payments on revolving facility (371,800) (1,289,800) (829,601)
Payments on term loan debt (18,750) 0 0
Proceeds from issuance of senior notes 0 0 400,000
Proceeds from other financing agreements 6,214 0 0
Deferred financing costs paid (4,468) (8,206) (6,216)
Payments on financing lease liabilities (2,876) (2,867) (2,219)
Net cash (used in) provided by financing activities (139,905) 581,947 (258,753)
Net (decrease) increase in cash and cash equivalents (4,215) 3,678 49
Cash and cash equivalents at the beginning of the period 7,970 4,292 4,243
Cash and cash equivalents at the end of the period 3,755 7,970 4,292
Cash paid during the period for:      
Interest 136,420 78,148 44,633
Income taxes 20 43 34
Non-cash investing activities:      
(Decrease) increase in accrued capital expenditures and other (14,765) (10,428) 3,850
Non-cash financing activities:      
Non-cash lease liability arising from obtaining right of use assets during the period $ 4,966 $ 12,717 $ 9,457